ArticleBMC dermatology2014

Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report.

Sara Falivene et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.